Achievements
FEBRUARY 2025
- TEST LICENCE APPROVED
- ONE MORE PATENT GRANTED
OCTOBER 2024
- FILED THE PATENT OF ADDITION
- FOLLOW UP INSPECTION BY CDSCO
- SUBMISSION OF REQUESTED DOCUMENTS TO CDSCO
- SUBMITTED A PATENT DRAFT FOR QRLBIO-002
AUGUST 2024
- JOINT INSPECTION BY REGULATORY AGENCIES
APRIL 2024
- MOVING TO A NEW FACILITY
JANUARY 2024
- RECEIVED SEED FUNDING FROM ANGEL INVESTORS
NOVEMBER 2023
- APPLIED FOR NEW DRUG TEST LICENSE
OCT 2023
- COMPLETED ADDIONAL STUDIES ON QRLBIO-001
APRIL 2023
- CONVERTED TO PVT LTD COMPANY
OCTOBER 2022
- RECEIVED SEED GRANT FROM GOVT. OF GUJARAT
MARCH 2021
- INCORPORATED AS LLP
DECEMBER 2021
- COMPETED R&D, VALIDATION OF PRODUCT QRLBIO-001
JANUARY 2020
- RECEIVED GRANT OF FROM DSIR AND STARTING R&D OF PRODUCT DEVELOPMENT
ABOUT US
QRL Bioscience Private Limited
CIN: U72200GJ2023PTC140362
QRL Bioscience has developed Autologous Advanced Biologics (AAB) platform to develop novel therapeutics for treating chronic degenerative diseases such as chronic wounds and osteoarthritis.
LINKS
CONTACT US
Plot No. E7+E8/13, First Floor, GIDC Electronic Estate, Sector 26, Gandhinagar - 382023
+919879514046
info.qrlbioscience@gmail.com
Copyright © 2025 QRL Bioscience Private Limited. All rights reserved.
Designed & Developed By : UiX Studios LLP